Investigating how drugs behave in the body for nervous system diseases.
Official title: SRI 2023 RODENT AND NON-RODENT PHARMACOKINETIC STUDIES
Funded at Sri International · NIH-11046445 · Data updated 2026-11-12
This study is looking at how different medications work in the body to help improve treatments for people with neurological disorders, so that patients can have better options for managing their conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project start | July 3, 2023 |
| Project end | July 2, 2026 |
| Funding year | 2024 |
| Award (this year) | $176,606 |
| NIH project number | 271201600006I-P00001-759502300001-1 |
| Project ID | NIH-11046445 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from various neurological disorders who may benefit from new therapeutic interventions.
✕Less likely to help
Patients with non-neurological conditions or those not affected by nervous system diseases may not receive any benefit from this research.
What this research studies
This research focuses on understanding the pharmacokinetics, or how drugs move through the body, specifically for treatments targeting neurological disorders. By conducting studies on both rodent and non-rodent models, the research aims to gather critical data that can inform the development of effective therapies. Patients may benefit from improved treatment options as the findings could lead to better-targeted interventions for various nervous system diseases. The approach involves detailed management and operational support to ensure accurate and reliable results.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies for patients with neurological disorders.
How similar studies have gone: Other research in pharmacokinetics has shown success in improving drug therapies for various conditions, indicating that this approach is promising.
Where this research is happening
-
Sri International
Menlo Park, United States Active
Researchers
- Principal investigator: Ho, Lynne — Sri International
- Study coordinator: Ho, Lynne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.